DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Dalakas MC, Rakocevic G, Schmidt J , et al.
Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis.
Brain 2009;
132 (Pt 6) 1536-1544
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.